<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">475831969</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180406123842.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170329e20000401xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s100960050460</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s100960050460</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Infection Caused by Nocardia farcinica</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="b">Case Report and Review</subfield>
   <subfield code="c">[O. H. Torres, P. Domingo, R. Pericas, P. Boiron, J. A. Montiel, G. Vázquez]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a"> Nocardia farcinica is a rare Nocardia species causing localised and disseminated infections. A case of Nocardia farcinica infection is presented, and 52 cases previously reported in the literature are reviewed. The hosts usually had predisposing conditions (85%), and acquired the infection through the respiratory tract or skin; the infection then often spread to the brain, kidney, joints, bones and eyes. Pulmonary or pleural infections (43%), brain abscesses (30%) and wound infections (15%) which failed to respond to conventional antimicrobial therapy were the more frequent forms of infection. Nocardia farcinica was frequently isolated from pus (100% of samples), bronchial secretions (41%) and biopsy specimens (63%), but isolation from blood and urine, as in the case presented here, is rare. Antibiotic therapy was adequate in 61% of the patients in whom it was specified, the agents most frequently given being trimethoprim-sulfamethoxazole (54%), amikacin combined with imipenem (7%) and amoxicillin-clavulanate (7%). The high mortality (31%) can be attributed to the severe underlying diseases present, difficulties encountered in identifying the pathogen, inappropriate therapy and late initiation of therapy. Although an infrequent pathogen, Nocardia farcinica should be kept in mind as a cause of infection especially in immunosuppressed patients with indolent infections not responding to third-generation cephalosporins.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag Berlin Heidelberg, 2000</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Torres</subfield>
   <subfield code="D">O. H.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Domingo</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Pericas</subfield>
   <subfield code="D">R.</subfield>
   <subfield code="u">Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Boiron</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Laboratoire de Mycologie Fondamentale, et Appliquée aux Biotechnologies Industrielles, Faculté de Pharmacie, Institut des Sciences Pharmaceutiques et Biologiques, 8, Avenue Rockefeller, 69373 Lyon Cedex 08, France, FR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Montiel</subfield>
   <subfield code="D">J. A.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Vázquez</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s100960050460</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s100960050460</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Torres</subfield>
   <subfield code="D">O. H.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Domingo</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Pericas</subfield>
   <subfield code="D">R.</subfield>
   <subfield code="u">Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Boiron</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Laboratoire de Mycologie Fondamentale, et Appliquée aux Biotechnologies Industrielles, Faculté de Pharmacie, Institut des Sciences Pharmaceutiques et Biologiques, 8, Avenue Rockefeller, 69373 Lyon Cedex 08, France, FR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Montiel</subfield>
   <subfield code="D">J. A.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Vázquez</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">Department of Internal Medicine (Infectious Diseases Unit), Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Avinguda, Sant Antoni Ma Claret 167, 08025 Barcelona, Spain e-mail: pere.domingo@cc.uab.es, ES</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
